CorVel (NASDAQ:CRVL) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of CorVel (NASDAQ:CRVL) from a hold rating to a buy rating in a report issued on Sunday.

Separately, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of CorVel in a research note on Saturday, September 27th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of “Hold”.

CorVel Stock Up 0.9%

NASDAQ:CRVL opened at $72.04 on Friday. CorVel has a 12-month low of $70.48 and a 12-month high of $128.61. The firm has a market capitalization of $3.70 billion, a P/E ratio of 37.13 and a beta of 0.95. The stock’s fifty day simple moving average is $83.34 and its 200-day simple moving average is $98.12.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings results on Tuesday, August 5th. The business services provider reported $0.52 earnings per share (EPS) for the quarter. CorVel had a return on equity of 32.31% and a net margin of 10.98%.The business had revenue of $234.71 million for the quarter.

Insider Activity

In other CorVel news, insider Maxim Shishin sold 12,000 shares of CorVel stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $89.16, for a total value of $1,069,920.00. Following the sale, the insider owned 7,050 shares of the company’s stock, valued at $628,578. This trade represents a 62.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Brandon O’brien sold 1,764 shares of CorVel stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $91.54, for a total value of $161,476.56. Following the completion of the sale, the chief financial officer directly owned 8,948 shares in the company, valued at approximately $819,099.92. This represents a 16.47% decrease in their position. The disclosure for this sale can be found here. Company insiders own 44.56% of the company’s stock.

Institutional Trading of CorVel

A number of hedge funds and other institutional investors have recently modified their holdings of CRVL. Farther Finance Advisors LLC increased its position in shares of CorVel by 44.7% in the first quarter. Farther Finance Advisors LLC now owns 816 shares of the business services provider’s stock valued at $93,000 after acquiring an additional 252 shares during the last quarter. GAMMA Investing LLC increased its position in shares of CorVel by 58.6% in the first quarter. GAMMA Investing LLC now owns 685 shares of the business services provider’s stock valued at $77,000 after acquiring an additional 253 shares during the last quarter. SG Americas Securities LLC increased its position in shares of CorVel by 519.5% in the first quarter. SG Americas Securities LLC now owns 9,416 shares of the business services provider’s stock valued at $1,054,000 after acquiring an additional 7,896 shares during the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of CorVel in the first quarter valued at about $1,398,000. Finally, Wealth Enhancement Advisory Services LLC increased its position in shares of CorVel by 3.3% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 14,345 shares of the business services provider’s stock valued at $1,606,000 after acquiring an additional 461 shares during the last quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.